Epigenetic mechanism and target therapy of UHRF1 protein complex in malignancies

被引：23
|
作者：
Xue, Busheng [1 ]
Zhao, Jiansong [1 ]
Feng, Penghui [2 ]
Xing, Jia [3 ]
Wu, Hongliang [1 ]
Li, Yan [1 ]
机构：
[1] China Med Univ, Shengjing Hosp, Dept Spine & Joint Surg, 36 Sanhao St, Shenyang 110004, Peoples R China
[2] China Med Univ, Dept Obstet & Gynecol, Reprod Med Ctr, Shengjing Hosp, Shenyang, Peoples R China
[3] China Med Univ, Dept Histol & Embryol, Basic Med Coll, Shenyang, Peoples R China
来源：
ONCOTARGETS AND THERAPY | 2019年 / 12卷
基金：
中国国家自然科学基金;
关键词：
UHRF1 protein complex; epigenetic modification; ICBP90; RING FINGER DOMAINS; LYSINE METHYLTRANSFERASE G9A; HEMI-METHYLATED DNA; HISTONE H3 TAIL; CELL-PROLIFERATION; UBIQUITIN-LIKE; BLADDER-CANCER; SRA DOMAIN; REPLICATION MACHINERY; STRUCTURAL INSIGHT;
D O I：
10.2147/OTT.S192234
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
Ubiquitin-like with plant homeodomain and really interesting new gene finger domains 1 (UHRF1) functions as an epigenetic regulator recruiting PCNA, DNMT1, histone deacetylase 1, G9a, SuV39H, herpes virus-associated ubiquitin-specific protease, and Tat-interactive protein by multiple corresponding domains of DNA and H3 to maintain DNA methylation and histone modifications. Overexpression of UHRF1 has been found as a potential biomarker in various cancers resulting in either DNA hypermethylation or global DNA hypo-methylation, which participates in the occurrence, progression, and invasion of cancer. The role of UHRF1 in the reciprocal interaction between DNA methylation and histone modifications, the dynamic structural transformation of UHRF1 protein within epigenetic code replication machinery in epigenetic regulations, as well as modifications during cell cycle and chemotherapy targeting UHRF1 are evaluated in this study.
引用
收藏
页码：549 / 559
页数：11
相关论文
共 50 条
  • [41] Epigenetic regulator UHRF1 orchestrates proinflammatory gene expression in rheumatoid arthritis in a suppressive manner
    Saeki, Noritaka
    Inoue, Kazuki
    Ideta-Otsuka, Maky
    Watamori, Kunihiko
    Mizuki, Shinichi
    Takenaka, Katsuto
    Igarashi, Katsuhide
    Miura, Hiromasa
    Takeda, Shu
    Imai, Yuuki
    JOURNAL OF CLINICAL INVESTIGATION, 2022, 132 (11):
  • [42] Interaction of the epigenetic integrator UHRF1 with the MYST domain of TIP60 inside the cell
    Waseem Ashraf
    Christian Bronner
    Liliyana Zaayter
    Tanveer Ahmad
    Ludovic Richert
    Mahmoud Alhosin
    Abdulkhaleg Ibrahim
    Ali Hamiche
    Yves Mely
    Marc Mousli
    Journal of Experimental & Clinical Cancer Research, 36
  • [43] Epigenetic ALYREF/UHRF1/RHOB Axis in Corneal Wound Healing and Implications for Epithelial Tumorigenesis
    Zhang, Hua
    Lan, Shuning
    Ren, Disuo
    Chen, Xiaoyan
    Lin, Yong
    Cao, Qiongjie
    Xu, Weiwei
    Wang, Jiao
    Reinach, Peter Sol
    Yan, Dongsheng
    Luo, Guangying
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2025, 66 (03)
  • [44] Targeting microRNA/UHRF1 pathways as a novel strategy for cancer therapy (Review)
    Choudhry, Hani
    Zamzami, Mazin A.
    Omran, Ziad
    Wu, Wei
    Mousli, Marc
    Bronner, Christian
    Alhosin, Mahmoud
    ONCOLOGY LETTERS, 2018, 15 (01) : 3 - 10
  • [45] TIP60 governs the auto-ubiquitination of UHRF1 through USP7 dissociation from the UHRF1/USP7 complex
    Ahmad, Tanveer
    Ashraf, Waseem
    Ibrahim, Abdulkhaleg
    Zaayter, Liliyana
    Muller, Christian D.
    Hamiche, Ali
    Mely, Yves
    Bronner, Christian
    Mousli, Marc
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2021, 59 (05)
  • [46] Defining ortholog-specific UHRF1 inhibition by STELLA for cancer therapy
    Bai, Wenjing
    Xu, Jinxin
    Gu, Wenbin
    Wang, Danyang
    Cui, Ying
    Rong, Weidong
    Du, Xiaoan
    Li, Xiaoxia
    Xia, Cuicui
    Gan, Qingqing
    He, Guantao
    Guo, Huahui
    Deng, Jinfeng
    Wu, Yuqiong
    Yen, Ray-Whay Chiu
    Yegnasubramanian, Srinivasan
    Rothbart, Scott B.
    Luo, Cheng
    Wu, Linping
    Liu, Jinsong
    Baylin, Stephen B.
    Kong, Xiangqian
    NATURE COMMUNICATIONS, 2025, 16 (01)
  • [47] The DNMT1/PCNA/UHRF1 disruption induces tumorigenesis characterized by similar genetic and epigenetic signatures
    Romain Pacaud
    Emeline Brocard
    Lisenn Lalier
    Eric Hervouet
    François M. Vallette
    Pierre-François Cartron
    Scientific Reports, 4
  • [48] Diosgenin inhibits prostate cancer progression by inducing UHRF1 protein degradation
    Peng, Yuchong
    Tang, Rong
    Ding, Liuyang
    Zheng, Rirong
    Liu, Youhong
    Yin, Linglong
    Fu, Yongming
    Deng, Tanggang
    Li, Xiong
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2023, 942
  • [49] Regulatory mechanism and biological function of UHRF1–DNMT1-mediated DNA methylation
    Yifan Ren
    Functional & Integrative Genomics, 2022, 22 : 1113 - 1126
  • [50] The DNMT1/PCNA/UHRF1 disruption induces tumorigenesis characterized by similar genetic and epigenetic signatures
    Pacaud, Romain
    Brocard, Emeline
    Lalier, Lisenn
    Hervouet, Eric
    Vallette, Francois M.
    Cartron, Pierre-Francois
    SCIENTIFIC REPORTS, 2014, 4
12345